Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Bright Light on Sex Hormones and Ovulation in Humans
This study has been completed.
First Received: May 17, 2006   Last Updated: November 29, 2006   History of Changes
Sponsored by: Russian Academy of Medical Sciences
Information provided by: Russian Academy of Medical Sciences
ClinicalTrials.gov Identifier: NCT00327366
  Purpose

The study investigated whether bright artificial light may influence menstrual cycle and ovulation conclusively, and what underlying hormonal changes for this effect are.


Condition Intervention
Anovulation
Procedure: Light therapy

Study Type: Interventional
Study Design: Non-Randomized, Single Blind, Placebo Control, Crossover Assignment, Efficacy Study

Further study details as provided by Russian Academy of Medical Sciences:

Study Start Date: September 2003
Estimated Study Completion Date: November 2003
Detailed Description:

Several studies have shown a shortening of the menstrual cycle following light therapy in women with abnormally long menstrual cycles or with winter depression, which suggests that bright light may influence sex hormones and ovulation. The study was designed to investigate this possibility. Twenty-two women with slightly lengthened menstrual cycles and without clinically evident endocrine abnormalities completed a study lasting for two menstrual cycles separated by an off-protocol episode of at least 1 menstrual cycle. Bright light therapy was administered for a week at home during one experimental cycle, and dim light during another cycle (placebo-controlled, crossover, counter-balanced order). Daytime blood sampling and ultrasound scan were performed before and after a week of light therapy, on the ~7th and 14th days after menstruation onset.

Ultrasound examination was repeated further to document ovulation. Serum was assayed for thyroid-stimulating hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol. The preliminary results were reported at the SLTBR meeting in June, 2005.

  Eligibility

Ages Eligible for Study:   19 Years to 40 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • Age 19-40 years
  • Mean menstrual cycle 28-38 days
  • Good general health
  • Generally normal sleep-wake regimen
  • Motivated for free participation

Exclusion Criteria:

  • Low cooperation
  • Medications known to interfere with hormone release
  • Clinically evident endocrine abnormalities including the signs of
  • Hyperandrogenism
  • Travel over several time zones during two months prior the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00327366

Sponsors and Collaborators
Russian Academy of Medical Sciences
Investigators
Principal Investigator: Konstantin V. Danilenko, MD Institute of Internal Medicine SB RAMS
  More Information

No publications provided

Study ID Numbers: M-s3
Study First Received: May 17, 2006
Last Updated: November 29, 2006
ClinicalTrials.gov Identifier: NCT00327366     History of Changes
Health Authority: Russia: Pharmacological Committee, Ministry of Health

Keywords provided by Russian Academy of Medical Sciences:
Menstrual Cycle
Light Therapy
Sex Hormones
Ovulation

Study placed in the following topic categories:
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Endocrinopathy
Ovarian Diseases
Anovulation
Hormones

Additional relevant MeSH terms:
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Ovarian Diseases
Anovulation
Adnexal Diseases

ClinicalTrials.gov processed this record on September 01, 2009